Adaptin Bio (APTN) Accounts Payables (2022 - 2026)

Adaptin Bio (APTN) has 5 years of Accounts Payables data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 319.29% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 319.29% YoY), and the FY2025 full-year result was $1.5 million, up 11.09% from the prior year.
• Accounts Payables declined to $1.4 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.5 million in Q4 2025 to a low of $58.0 in Q4 2023.
• A 5-year average of $564688.8 and a median of $190091.5 in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables slumped 99.54% in 2023 and soared 2346591.38% in 2024, its largest moves.
• Tracing APTN's Accounts Payables over 5 years: stood at $12500.0 in 2022, then tumbled by 99.54% to $58.0 in 2023, then soared by 2346591.38% to $1.4 million in 2024, then rose by 11.09% to $1.5 million in 2025, then fell by 9.31% to $1.4 million in 2026.
• Business Quant data shows APTN's Accounts Payables at $1.4 million in Q1 2026, $1.5 million in Q4 2025, and $1.3 million in Q3 2025.